Recent

% | $
Quotes you view appear here for quick access.

RPX Corporation Message Board

  • investora2z investora2z Apr 19, 2013 9:19 AM Flag

    Showing some positive signs

    The correction over the last few weeks is perhaps getting over. Yesterday RPXC showed some signs, with a rise accompanied with increased volumes. The volume yesterday was 382K shares compared with the 3 month average of 293K shares. A few more days of rise with increasing volumes would set the stock on the path for taking out the 50 DMA of $13.48. However, the real resistance which is required to be overcome for changing the medium term trend is $14.50. For that, the momentum has to remain strong till the results. Thereafter, if the earnings beat expectations, then a new leg of the uptrend may start. Already the stock is significantly above the recent lows of $8.55. The recent break below the 50 DMA has made the stock weak, but it seems that it may show some resilience till the earnings. Over the years, the fundamentals have improved, and even last year the growth rate was around 28%. The services revenues are likely to increase as the market for patent monetization increases. Companies are becoming pure patent plays and going all out to license / enforce their patent rights. There are companies like Document Security System (NYSE:DSS), with a more balanced business model which not solely dependent on the value of the IPRs. In a recent report, analyst and researcher JP Moreno has highlighted the possible synergies between DSS's recent IPR acquisitions and its $17 million business. Of course, the report mainly stressed on the huge possible upside in the stock based on a patent infringement lawsuit filed by its subsidiary against Facebook (FB), LinkedIn (LNKD), Novell (NOVL), Broadvision (BVSN) and Jive Software (JIVE). For RPXC, the market is growing, and if it can increase its market share, then the investors will be able to reap rich rewards. The near term future will be dependent on the results.

 
RPXC
13.70+0.19(+1.41%)Aug 27 4:00 PMEDT